Shionogi & Co., Ltd.

2018/05/18: Audio Webcasting of FY2017 Financial Results
2018/05/10: FY2017 Financial Results
2018/05/09: Notice regarding introduction of a Restricted Stock Compensation Plan and a change of compensation amount for Directors
2018/05/09: Shionogi to Announce Executive Appointment
2018/04/23: Shionogi Establishes New Manufacturing Subsidiary in Japan
2018/04/23: Notice of Revisions to Dividend Forecasts
2018/04/19: SHIONOGI TO PRESENT NEW DATA AT 2018 EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
2018/04/17: SHIONOGI ENTERS INTO LICENSE AGREEMENT WITH PHARMBIO KOREA FOR OSPEMIFENE
2018/03/26: Research Collaboration between Kyoto University and Shionogi at Kyoto University’s open innovation laboratory -Drug discovery and medical research for the treatment of psychiatric disorders-
2018/03/23: Audio Webcasting of the R&D Meeting
2018/03/22: Shionogi Announces Agreement with CARB-X for an Innovative AMR (Anti Microbial Resistance) Program
2018/03/19: Shionogi to Announce Executive Appointments
2018/03/15: R&D Meeting